Mackay Shields LLC’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-65,100
Closed -$778K 1006
2021
Q1
$778K Sell
65,100
-27,700
-30% -$335K 0.01% 1076
2020
Q4
$1.15M Sell
92,800
-97,200
-51% -$1.05M 0.01% 1046
2020
Q3
$1.99M Sell
190,000
-23,600
-11% -$300K 0.01% 793
2020
Q2
$2.99M Sell
213,600
-9,000
-4% -$122K 0.02% 585
2020
Q1
$2.62M Sell
222,600
-18,900
-8% -$250K 0.02% 553
2019
Q4
$3.42M Buy
+241,500
New +$2.96M 0.02% 648

Other funds holding INVA

Mackay Shields LLC's INVA Position: Q2 2021 in Review

Mackay Shields LLC sold out of Innoviva (INVA) in Q2 2021, closing a stake of 65,100 shares — an estimated $778K sold.

Mackay Shields LLC first reported a position in INVA in Q4 2019 and held it in 6 quarters. The position peaked at $3.42M in Q4 2019. 185 funds tracked by Wall St. Rank hold INVA as of Q2 2021.

  • Mackay Shields LLC reported no remaining Innoviva position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 65,100 Innoviva shares in Q2 2021, an estimated $778K.
  • Mackay Shields LLC first reported a position in Innoviva in Q4 2019 and held it in 6 quarters.
  • Mackay Shields LLC's Innoviva position peaked at $3.42M in Q4 2019.
  • 185 funds tracked by Wall St. Rank held Innoviva as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.